On Wednesday, 18th of September 2024, Bioarchitech attended the event Future Directions: mRNA Technology in the UK, organized by Imperial Business Partners (IBP) and sponsored by Moderna and CSL Seqirus. The event provided an in-depth look at the current landscape of mRNA technologies, including advancements in artificial intelligence for vaccine development and emerging clinical applications of mRNA. Over 75 of the UK’s leading scientists, clinicians, and industry experts gathered to discuss cutting-edge innovations and the UK’s potential as a global leader in life sciences.

For Bioarchitech, the event presented valuable opportunities to connect with potential partners for lipid nanoparticle (LNP) development and engage in open discussions with regulatory bodies about preclinical testing requirements before clinical advancement.